Loading company…
Rescond develops AED systems and training products for emergency response to ventricular arrhythmias.
Founded in 2017 and based in Xi'an, China, Rescond develops cardioversion systems for malignant ventricular arrhythmias. Its products include AEDs, training machines, accessories, and consumables for settings such as sports venues and transport hubs. The company closed a pre-Series A funding round in September 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in